Jane Street
GCVRZ

Jane Street’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Jane Street’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-10,844
Closed -$21K – 3644
2013
Q2 		$21K Buy
+10,844
New +$19.1K ﹤0.01% 2595

Other funds holding GCVRZ

ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
DI
Dalton Investments Las Vegas, Nevada $103M AUM 3.77% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
AAA
Alpine Associates Advisors Englewood Cliffs, New Jersey $158M AUM 48.85% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Jane Street's GCVRZ Position: Q3 2013 in Review

Jane Street sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2013, closing a stake of 10,844 shares — an estimated $21K sold.

Jane Street first reported a position in GCVRZ in Q2 2013 and held it in 1 quarter. The position peaked at $21K in Q2 2013. 136 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2013.

  • Jane Street reported no remaining Sanofi Contingent Value Rights position as of Q3 2013 after selling out during the quarter.
  • Jane Street sold 10,844 Sanofi Contingent Value Rights shares in Q3 2013, an estimated $21K.
  • Jane Street first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 1 quarter.
  • Jane Street's Sanofi Contingent Value Rights position peaked at $21K in Q2 2013.
  • 136 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2013.

Based on Jane Street's 13F filing for Q3 2013, filed 15 Nov 2013.